BLS Polymers manufactures custom-formulated polymer compounds used to insulate, sheath and jacket wires and cables in the telecom, power and railway sectors, and as adhesive and HDPE layers in three-layer polyethylene (3LPE) coatings that protect underground oil, gas and water pipelines. The range covers HDPE, MDPE, LLDPE, XLPE, halogen-free flame-retardant (HFFR), PVC, cable-filling and adhesive coating compounds. It is a B2B supplier, selling directly to cable and pipe-coating manufacturers, with telecom the largest revenue contributor followed by water distribution, power and oil & gas. The company is incorporated in 1991, is promoted by Vinod Aggarwal, Sushil Aggarwal and Madhukar Aggarwal, and is described as part of the BLS Group.

Its pre-approved enlistments with a Maharatna and a Navratna CPSE, plus Miniratna and state-government vendor listings, are a genuine qualification moat in a fragmented segment, because a compound must be approved for each cable specification before orders flow. The flip side is concentration: one plant, one end-market cluster (cables) and a customer base dependent on infrastructure spending cycles.

IPO Structure at a Glance

Three things stand out. First, revenue has barely grown (₹317 crore in FY23 to ₹349 crore in FY26, a low-single-digit CAGR) while PAT has quadrupled, so the earnings story is margin expansion, not volume. Second, margins stepped up sharply from FY25; the IPO-review consensus from independent commentators is that the sustainability of this jump deserves scrutiny in a competitive, fragmented segment. Third, the Q1 FY27 quarter (EBITDA margin 15.1%, PAT ₹10.2 crore) continues the trend, annualising to about ₹41 crore of PAT. Average three-year RoNW is about 27%, but this is on a thin pre-IPO equity base; trade receivables of ₹95.2 crore at June 2026 (about 81 days of annualised sales) and contingent liabilities of ₹14.2 crore are watch items. No dividend has been paid to date; a policy was adopted in April 2025.

Even at an 11% WACC and 6% terminal growth the DCF stays below the ₹150 issue price, so the issue price is not supported on a cash-flow basis unless margins hold well above 14% for a decade. Early-year FCFF is negative because of the expansion capex and the heavy working-capital needs of a receivable-intensive B2B model.

A weighted peer multiple (Kingfa 20%, DDev 40%, Plastiblends 40%) is about 16x. A 20% premium for higher RoCE, CPSE empanelment and capacity growth gives roughly 19x, applied to FY27E EPS of about ₹6.4 on post-issue shares (PAT ₹39.5 crore including modest treasury income), for a relative fair value of ₹123 per share. Independent reviewers note the peer set is not a like-for-like comparison, so this method carries judgement. The pricing is fair-to-slightly-aggressive according to one broker and aggressive according to another, which brackets the range between ₹123 and the issue price.

Post-issue NAV is ₹56.41 per share (pre-issue NAV at June 2026 was ₹23.35), so the issue price represents 2.66x post-issue book (6.42x pre-issue book). A justified P/B of (ROE − g) / (COE − g) with a post-deployment ROE of 16%, cost of equity 12% and growth 5% gives 1.57x, or ₹89 per share. The sensitivity is large: 14% ROE gives ₹73 and 18% ROE gives ₹105. Note that annualised Q1 PAT of ₹41 crore on post-issue equity of about ₹350 crore is only a ~12% ROE until the fresh capital is deployed, which is the central tension in the valuation: past RoNW above 25% was earned on an equity base the IPO will more than triple.

EPV capitalises sustainable no-growth earnings at the cost of capital. FY26 EBIT (EBITDA ₹46.6 crore less assumed D&A of 1.8% of sales) is about ₹40 crore; after 25.2% tax and a 12% capitalisation rate, EV is about ₹251 crore, giving ₹74 per share after the cash bridge. On the Q1 FY27 annualised run-rate EV is about ₹356 crore, giving ₹91 per share. The EPV range of ₹74–₹91 (midpoint ₹83) tells readers how much of the ₹150 price is paying for growth and margin persistence rather than demonstrated earnings power: roughly 40–50% of it.

BLS is effectively a single-business company and does not disclose segment margins, so an SOTP is indicative only and carries a smaller weight. Splitting FY27E EBITDA of about ₹56 crore by revenue mix (wire & cable about 80%, pipeline coating and others about 20%) and applying 9x and 8x EV/EBITDA respectively gives a blended 8.8x, an EV of about ₹493 crore and, after the same cash bridge, ₹113 per share.

Overlay logic. Positives: 3.9x subscription on day 1, 11.9x on day 2 and 42x by the morning of day 3 (NII about 101x, retail about 34x, QIB about 12x), grey-market premium reported at ₹18–₹29 (12–19%), and Subscribe calls from several brokers. These support listing-day pricing but not intrinsic value, so they carry no uplift to fair value. Negatives: the aggressive-pricing view of a veteran IPO reviewer, a sharp, recent margin step-up, ₹95 crore of receivables, a single plant, 46 untraceable shareholders holding about 3.3 lakh shares, and a lead manager whose 7 of 23 recent issues closed below offer price on listing day. These justify a 5% discount to the weighted value. Fair value of ₹104 compares with ₹150 at the upper band, i.e. the issue is priced about 44% above estimated fair value.

These zones would be regarded as levels at which price and estimated value are better aligned, and they sit well below the ₹142–₹150 band. Post-listing price discovery, rather than the IPO itself, is where such levels would most plausibly arise.

The probability-weighted 12-month value is about ₹122, below the ₹150 issue price. A holder at ₹150 therefore faces a base case of roughly −17% unless listing-day and early-trading sentiment run ahead of fundamentals.

Drivers. Capacity expansion at Goa funded by ₹77.56 crore of IPO proceeds; telecom and power-cable demand from network and grid build-outs; HFFR and XLPE value-added grades with better margins; railway and water-pipeline coating demand; and ₹89.5 crore of working capital to support larger orders. Revenue has been flat over three years, so the growth thesis depends on the new capacity filling quickly.

Estimated PAT path: about ₹39.5 crore (FY27E), ₹45.7 crore (FY28E) and ₹50.8 crore (FY29E), against ₹27.0 crore in FY26. Per-lot figures assume the 100-share lot at ₹150 (₹15,000) and exclude brokerage and taxes. For retail applicants the allotment odds are also a factor: at the day-3 morning retail subscription of about 33.6x, a single-lot application would have roughly a 1-in-34 chance of allotment, so the expected listing gain per application is modest even if the grey-market premium holds. Final-day demand will change this.

Before the IPO the company was almost entirely promoter-held, so there is no institutional shareholding history or named fund-house holder list to report; the post-issue columns assume full allotment in each category and are derived from the issue structure. The seven anchor investors (sources report six or seven) put in ₹76.5 crore at the upper band; their individual names were not available in the sources reviewed, so none are listed here. Anchor lock-ins typically release in two stages (about 30 and 90 days after allotment), which may add supply to the stock after listing. Readers may check BSE/NSE shareholding filings after listing for entity-level detail.

What is the BLS Polymers IPO price band and lot size?

The price band is ₹142 to ₹150 per share, with a minimum lot of 100 shares (₹15,000 at the upper band). Bidding runs 27–29 Oct 2026.

What is the BLS Polymers share price target?

This analysis estimates a fair value of about ₹104 per share, within a ₹90–₹125 range, and a 12-month base-case value of about ₹125. These are estimates and not guarantees.

Is the BLS Polymers IPO overvalued?

At ₹150, the issue is priced at 34.5x FY26 earnings on post-issue shares and 2.66x post-issue book value, and about 44% above the estimated fair value, so it may be viewed as richly valued.

What is the BLS Polymers IPO GMP?

Unofficial grey-market premium has been reported at ₹18–₹29 (12–19%) across trackers. GMP changes quickly and does not guarantee the listing price.

When will BLS Polymers list?

Allotment is expected on 30 Oct 2026 and listing on BSE and NSE on 3 Nov 2026, subject to change.